Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Chang

Showing results (361-370 of 386) with videos related to

Pageof 39
Sort By:
Carcinogenesis|July 30, 2010
Inherited variation in immune genes and pathways and glioblastoma riskJudith A Schwartzbaum, Yuanyuan Xiao, Yanhong Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2017
Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive GlioblastomaSara A Byron, Nhan L Tran, Rebecca F Halperin, et al.
Neuro-Oncology|November 4, 2024
Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO resect groupPhilipp Karschnia, Jacob S Young, Gilbert C Youssef, et al.
Neuro-Oncology|June 9, 2019
Barriers to accrual and enrollment in brain tumor trialsEudocia Q Lee, Ugonma N Chukwueke, Shawn L Hervey-Jumper, et al.
BMJ Global Health|January 17, 2023
The creation of the Global Scales for Early Development (GSED) for children aged 0-3 years: combining subject matter expert judgements with big dataGareth McCray, Dana McCoy, Patricia Kariger, et al.
Nature Genetics|June 9, 2014
Variants near TERT and TERC influencing telomere length are associated with high-grade glioma riskKyle M Walsh, Veryan Codd, Ivan V Smirnov, et al.
Acta Neuropathologica|December 11, 2023
"De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockadeSara Hadad, Rohit Gupta, Nancy Ann Oberheim Bush, et al.
Neuro-Oncology|January 31, 2013
Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histologyTerri Rice, Shichun Zheng, Paul A Decker, et al.
Brain Pathology (Zurich, Switzerland)|November 25, 2021
Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomasEmily A Sloan, Rohit Gupta, Christian Koelsche, et al.
Neuro-Oncology|October 14, 2022
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directionsJulie J Miller, L Nicolas Gonzalez Castro, Samuel McBrayer, et al.
Pageof 39

Showing results (361-370 of 386) with videos related to

Sort By:
Pageof 39
Carcinogenesis|July 30, 2010
Inherited variation in immune genes and pathways and glioblastoma riskJudith A Schwartzbaum, Yuanyuan Xiao, Yanhong Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2017
Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive GlioblastomaSara A Byron, Nhan L Tran, Rebecca F Halperin, et al.
Neuro-Oncology|November 4, 2024
Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO resect groupPhilipp Karschnia, Jacob S Young, Gilbert C Youssef, et al.
Neuro-Oncology|June 9, 2019
Barriers to accrual and enrollment in brain tumor trialsEudocia Q Lee, Ugonma N Chukwueke, Shawn L Hervey-Jumper, et al.
BMJ Global Health|January 17, 2023
The creation of the Global Scales for Early Development (GSED) for children aged 0-3 years: combining subject matter expert judgements with big dataGareth McCray, Dana McCoy, Patricia Kariger, et al.
Nature Genetics|June 9, 2014
Variants near TERT and TERC influencing telomere length are associated with high-grade glioma riskKyle M Walsh, Veryan Codd, Ivan V Smirnov, et al.
Acta Neuropathologica|December 11, 2023
"De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockadeSara Hadad, Rohit Gupta, Nancy Ann Oberheim Bush, et al.
Neuro-Oncology|January 31, 2013
Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histologyTerri Rice, Shichun Zheng, Paul A Decker, et al.
Brain Pathology (Zurich, Switzerland)|November 25, 2021
Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomasEmily A Sloan, Rohit Gupta, Christian Koelsche, et al.
Neuro-Oncology|October 14, 2022
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directionsJulie J Miller, L Nicolas Gonzalez Castro, Samuel McBrayer, et al.
Pageof 39